Trial Details
COMPLETEDBasic Information
| Clinical ID | c3767 |
|---|---|
| Identifier | NCT01553591 |
| Trial Title | Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: Eluxadoline|DRUG: Placebo |
Participant Information
| Sponsor | Furiex Pharmaceuticals, Inc |
|---|---|
| City | Athens |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2012-05-29 |
|---|---|
| Primary Completion Date | 2014-07-29 |
| Completion Date | 2014-07-29 |